Purohit’s continued optimism is primarily driven by the strong commercial performance of Auvelity, the company’s treatment ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Boston Scientific (BSX – Research Report) and Axsome Therapeutics (AXSM – Rese ...

The Health Industry Series - ASEAN (tHIS ASEAN 2025), a groundbreaking event aimed at integrating healthcare resources across Southeast Asia, is set to take place in Kuala Lumpur during June 9-11.

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...

Kids Help Phone (KHP) is proud to announce that with a renewed commitment Co-operators has reached $1M in support of youth through KHP’s ...

Members of the media are invited to attend the Skyservice Business Aviation Hangar at the Ottawa airport for a tour of De ...

Contentstack, the headless CMS pioneer and category disruptor in digital experiences, today announced Josette Leslie as its new Chief Financial Officer. Based in New York City, Leslie brings over 25 ...

Bristol Myers Squibb today announced that the company will participate in the Goldman Sachs 46th Annual Global Healthcare Conference on Wednesday, June 11, 2025. The company will take part in a ...

Teva starts IND-enabling studies for BD9, a dual-target therapy for asthma and atopic dermatitis, under license from Biolojic ...

Hetero Labs could launch its generic sleep disorder drug as early as 2040 under a settlement deal with Axsome Therapeutics.

A development deal with Biogen Inc. could eventually bring City Therapeutics Inc. about $1 billion in milestone payments. Privately held City Therapeutics is getting $46 million in the deal. That ...